Clinical Trial Update: Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and tolerability of Tauroursodeoxycholic acid (TUDCA) in amyotrophic lateral sclerosis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Tauroursodeoxycholic acid (tauroursodeoxycholic acid)

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2014-11-26